crohn's disease Clinical Trials and Research
Also known as: crohn's, regional enteritis, ileitis, granulomatous enteritis, cd, inflammatory bowel disease · ICD-10: K50
Crohn's disease is a type of inflammatory bowel disease (IBD) causing chronic inflammation of the digestive tract. Research focuses on new treatments to reduce inflammation, manage symptoms, and improve quality of life. Find a Trial helps patients search for active studies.
Search crohn's disease trials →
Common questions about crohn's disease clinical trials
What are the different phases of clinical trials for Crohn's disease?
Clinical trials progress through phases (1, 2, 3, 4) to test safety and effectiveness. Early phases involve fewer participants, while later phases involve more, gathering extensive data before potential approval, according to NIH RePORTER.
Do clinical trials for Crohn's disease cost money to participate?
Generally, study-related medical care and investigational treatments are provided at no cost to participants. However, some costs like travel or lost wages might not be covered, as detailed on ClinicalTrials.gov.
What new treatments are being studied for Crohn's disease?
Current research explores novel biologic therapies, small molecule drugs, and personalized medicine approaches targeting specific inflammatory pathways. Studies also investigate dietary interventions and microbiome modulation, as reported on ClinicalTrials.gov and NIH RePORTER.
What types of interventions are common in Crohn's disease trials?
Trials often test new medications, including biologics and immunomodulators, designed to reduce inflammation and promote healing. Surgical techniques and lifestyle interventions are also sometimes evaluated, according to ClinicalTrials.gov.
Are there specific biomarkers used in Crohn's disease clinical trials?
Yes, researchers often use biomarkers like C-reactive protein (CRP), fecal calprotectin, and endoscopic scores to monitor disease activity and treatment response. Genetic markers are also being explored to predict disease course, based on NIH RePORTER data.
What might prevent someone from joining a Crohn's disease trial?
Common exclusion criteria can include active infections, certain co-existing medical conditions, pregnancy, or recent use of specific medications. These ensure participant safety and study integrity, as outlined in trial protocols on ClinicalTrials.gov.
What are the potential benefits and risks of participating in a Crohn's disease trial?
Potential benefits include access to new treatments and close medical monitoring. Risks can involve side effects from investigational drugs or the need for frequent visits and procedures, as detailed on ClinicalTrials.gov.
How to find a crohn's disease trial that fits you
- Describe your crohn's disease situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all crohn's disease trials →